Blog - Page 1030 of 5712

FridayApr 01, 2022 9:00 am

Nowigence Inc.’s Pluaris App Provides Ideal Solution for One Billion Knowledge Workers Around the World

Globally, there are one billion knowledge workers whose jobs require them to combine action with a level of domain expertise Providing these workers with information, tools they need to succeed is key Nowigence’s Pluaris app works 24/7 to turn narrative-intensive information into scrollable intelligence Cultivating and supporting a new generation of knowledge workers is “one of the great challenges of the modern era,” according to a recent “Forbes” article (https://ibn.fm/SZfZ4). Nowigence Inc. (NOWG) is up for the challenge, having created Pluaris, a powerful, proprietary platform that assists readers with automated reading and analysis of textual data. “There are currently about…

FridayApr 01, 2022 9:00 am

Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) CEO and Director Offers Shareholder Update on The Power Play by The Market Herald

Eat Well Group released a shareholder update letter from the company’s CEO and Director, Marc Aneed, on March 8, 2022, detailing the company’s history, the progress it has made so far along with the plans that it has for the new year While appearing on an interview on The Power Play by The Market Herald, Mr. Aneed covered the contents of the shareholder letter while also reiterating how optimistic he is for the company’s future He noted that, given the company’s investments so far, the company’s 2022 revenue projections now stand at between $90 million and $110 million On March…

FridayApr 01, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Continues to Showcase Ability to Improve Effectiveness of Existing Drug Brands

Health and wellness drug product innovator Lexaria Bioscience has developed a patented technology — DehydraTECH (TM) — which enhances the bioavailability of fat-soluble drugs and molecules Lexaria continues to research DehydraTECH’s ability to improve the speed and bioavailability of cannabidiol (“CBD”) in treating high blood pressure and epileptic conditions The company continues its research demonstrating the ability of its technology -to enhance the performance of antiviral drugs and other active pharmaceutical ingredients Sublicensing DehydraTECH continues to create revenues for the company Lexaria has additionally pursued the use of its drug-enhancing technology, in partnership with sublicensees, for making adult-use recreational cannabis…

ThursdayMar 31, 2022 1:42 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) CEO Featured in Recent Business Growth Pod Interview

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, and its CEO Ian Clifford is spotlighted in the latest episode of the Business Growth Pod. Clifford, who is also founder and director of FuelPositive, talked with host Allan Draper about the company, which is committed finding ways to reduce carbon emissions. During the interview, Clifford noted that the company believes that by concentrating on clean, economical technologies that build on existing approaches, it can impact the course of climate change. The Business Growth Pod, a podcast series designed specifically to…

ThursdayMar 31, 2022 12:57 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Commencement of Kernel Flow(R) Feasibility Study, Marking Exciting Moment for Psychedelic Drug Development

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that the first visit has been conducted in a Cybin-sponsored feasibility study. The study will focus on evaluating Kernel’s quantitative neuroimaging technology, Flow, to measure ketamine’s psychedelic effects on cerebral cortex hemodynamics. “The commencement of the Kernel feasibility study marks a truly exciting moment, not only for Cybin and Kernel, but also for the entire field of psychedelic drug development. To this point, studies have had to rely on subjective patient reporting,” said Cybin CEO Doug Drysdale. “By deploying the innovative Flow technology,…

ThursdayMar 31, 2022 12:37 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Eyes ‘Tip of the Iceberg’ Opportunity with Launch of Platinum Vape(TM) Live Resin in Michigan

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, together with its RWB Michigan LLC wholly owned subsidiary, today announced the debut of Platinum Vape(TM) (“PV”) Live Resin in Michigan. Previously available only in California and Oklahoma, PV Live Resin will soon be in the nearly 400 Michigan dispensaries that now carry Platinum products. “As promised, the Red White & Bloom team is introducing a steady stream of new products and consumption options to satisfy consumer demand in the rapidly growing Michigan cannabis market,” said Brad Rogers, Red White & Bloom chairman…

ThursdayMar 31, 2022 12:01 pm

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Releases Q4, Full-Year Results

Lottery.com (NASDAQ: LTRY), a leading technology company that is transforming how, where and when the lottery is played, is reporting its fourth-quarter and full-year 2021 revenue for the period ending Dec. 31, 2021. Q4 revenue totaled $21.5 million, an increase of $18.2 million over the previous year, with full-year revenue of $68.5 million, an increase of $61 million over 2020 numbers. The company also reported full-year 2021 pro forma revenue of $70.5 million, including acquired interest in Mexican entities, with full-year 2021 net loss of $9.3 million and adjusted EBITDA of $31.1 million. Corporate highlights include the company’s successful completion…

ThursdayMar 31, 2022 11:18 am

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Enters Agreement to Significantly Advance Technologies ‘Closer to the Clinic’

Silo Pharma (OTCQB: SILO) is a developmental stage biopharmaceutical company focused on the use of psychedelics as a therapeutic. Silo Pharma today announced its entry into an agreement with Frontage Laboratories, a contract research organization (“CRO”) providing integrated, science-driven, product development services throughout the drug discovery and development process that enable life science companies to achieve their drug development goals. “This agreement significantly advances our Central Nervous System Peptide, SPU-16, and our Joint Homing Peptide, SPU-21 technologies closer to the clinic,” said Eric Weisblum, CEO of Silo Pharma. “These solutions have the potential to enhance the therapeutic effect of current…

ThursdayMar 31, 2022 11:09 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces New Clinic Openings as Company’s Expansion Accelerates

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is opening Ketamine Wellness Centers (“KWC”) in Salt Lake City and Reno, Nevada, with additional locations planned to open this year. The company also announced that it is adding SPRAVATO(R), the first FDA-approved nasal spray, as a treatment option at three of its ketamine centers; the spray is intended to treat adults with treatment-resistant depression and depressive symptoms of major depressive disorder. In addition, the the company’s Delic Labs received Health Canada 56 exemptions to perform research and development work for several substances, including MDMA,…

ThursdayMar 31, 2022 9:35 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continues to Focus on the Continued Growth of its Top-Line Revenue and Bottom-Line Results in a Move to achieve its 3-Year Success Plan

RWB’s mission has always been to become the superior and most recognizable cannabis company in the United States It seeks to achieve this by focusing on the continued growth of top-line revenue and bottom-line results through brand expansion, mergers, and acquisitions So far, in 2022, the company has announced the acquisition of PharmaCo, which sees the transfer of 21 medical and adult-use cannabis licenses RWB has also closed a lease assignment on a critical manufacturing/processing and distribution facility in Michigan Its management is confident that the foundations laid down so far will aid in the company’s growth going forward In…

Site Search

Company Search

Nowigence Inc.’s Pluaris App Provides Ideal Solution for One Billion Knowledge Workers Around the World

Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) CEO and Director Offers Shareholder Update on The Power Play by The Market Herald

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Continues to Showcase Ability to Improve Effectiveness of Existing Drug Brands

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) CEO Featured in Recent Business Growth Pod Interview

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Commencement of Kernel Flow(R) Feasibility Study, Marking Exciting Moment for Psychedelic Drug Development

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Eyes ‘Tip of the Iceberg’ Opportunity with Launch of Platinum Vape(TM) Live Resin in Michigan

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Releases Q4, Full-Year Results

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Enters Agreement to Significantly Advance Technologies ‘Closer to the Clinic’

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces New Clinic Openings as Company’s Expansion Accelerates

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continues to Focus on the Continued Growth of its Top-Line Revenue and Bottom-Line Results in a Move to achieve its 3-Year Success Plan

Market Basics

Newsletter Publishers

Public Companies